JPH0711520B2 - How to make a permanent sample of cells - Google Patents
How to make a permanent sample of cellsInfo
- Publication number
- JPH0711520B2 JPH0711520B2 JP61226454A JP22645486A JPH0711520B2 JP H0711520 B2 JPH0711520 B2 JP H0711520B2 JP 61226454 A JP61226454 A JP 61226454A JP 22645486 A JP22645486 A JP 22645486A JP H0711520 B2 JPH0711520 B2 JP H0711520B2
- Authority
- JP
- Japan
- Prior art keywords
- cells
- permanent
- reacting
- specimen
- alkaline phosphatase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000004027 cell Anatomy 0.000 description 30
- 238000000034 method Methods 0.000 description 24
- 239000000975 dye Substances 0.000 description 14
- 239000000758 substrate Substances 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- 239000011347 resin Substances 0.000 description 7
- 229920005989 resin Polymers 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 6
- 210000001185 bone marrow Anatomy 0.000 description 6
- 238000002372 labelling Methods 0.000 description 6
- 239000008363 phosphate buffer Substances 0.000 description 6
- 108060003951 Immunoglobulin Proteins 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000007795 chemical reaction product Substances 0.000 description 5
- 238000005562 fading Methods 0.000 description 5
- 102000018358 immunoglobulin Human genes 0.000 description 5
- 210000002751 lymph Anatomy 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
- JUQPZRLQQYSMEQ-UHFFFAOYSA-N CI Basic red 9 Chemical compound [Cl-].C1=CC(N)=CC=C1C(C=1C=CC(N)=CC=1)=C1C=CC(=[NH2+])C=C1 JUQPZRLQQYSMEQ-UHFFFAOYSA-N 0.000 description 3
- 241000283707 Capra Species 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 229940052223 basic fuchsin Drugs 0.000 description 3
- 239000008393 encapsulating agent Substances 0.000 description 3
- 238000005538 encapsulation Methods 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000004807 localization Effects 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 210000005259 peripheral blood Anatomy 0.000 description 3
- 239000011886 peripheral blood Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 229960001614 levamisole Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- IPSIPYMEZZPCPY-UHFFFAOYSA-N new fuchsin Chemical compound [Cl-].C1=CC(=[NH2+])C(C)=CC1=C(C=1C=C(C)C(N)=CC=1)C1=CC=C(N)C(C)=C1 IPSIPYMEZZPCPY-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000001044 red dye Substances 0.000 description 2
- 235000010288 sodium nitrite Nutrition 0.000 description 2
- YNXICDMQCQPQEW-UHFFFAOYSA-N 1-naphthyl dihydrogen phosphate Chemical compound C1=CC=C2C(OP(O)(=O)O)=CC=CC2=C1 YNXICDMQCQPQEW-UHFFFAOYSA-N 0.000 description 1
- XCDIDHPTOCAKAB-UHFFFAOYSA-N 3-hydroxy-n-(2-methylphenyl)anthracene-2-carboxamide Chemical compound CC1=CC=CC=C1NC(=O)C1=CC2=CC3=CC=CC=C3C=C2C=C1O XCDIDHPTOCAKAB-UHFFFAOYSA-N 0.000 description 1
- JIEINYQEXWLMCU-UHFFFAOYSA-N 7-bromo-3-hydroxy-n-(2-methoxyphenyl)naphthalene-2-carboxamide Chemical compound COC1=CC=CC=C1NC(=O)C1=CC2=CC(Br)=CC=C2C=C1O JIEINYQEXWLMCU-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000017095 Leukocyte Common Antigens Human genes 0.000 description 1
- 108010013709 Leukocyte Common Antigens Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- IOMLBTHPCVDRHM-UHFFFAOYSA-N [3-[(2,4-dimethylphenyl)carbamoyl]naphthalen-2-yl] dihydrogen phosphate Chemical compound CC1=CC(C)=CC=C1NC(=O)C1=CC2=CC=CC=C2C=C1OP(O)(O)=O IOMLBTHPCVDRHM-UHFFFAOYSA-N 0.000 description 1
- HUXIAXQSTATULQ-UHFFFAOYSA-N [6-bromo-3-[(2-methoxyphenyl)carbamoyl]naphthalen-2-yl] dihydrogen phosphate Chemical compound COC1=CC=CC=C1NC(=O)C1=CC2=CC(Br)=CC=C2C=C1OP(O)(O)=O HUXIAXQSTATULQ-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- -1 benzidine compound Chemical class 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- 150000001989 diazonium salts Chemical class 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000012137 double-staining Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000003372 endocrine gland Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000011532 immunohistochemical staining Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000012758 nuclear staining Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 229920001084 poly(chloroprene) Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
【発明の詳細な説明】 (産業上の利用分野) 本発明は、細胞、組織など(本明細書では、これらを含
めて細胞という)の永久標本を作成する方法に関する。TECHNICAL FIELD The present invention relates to a method for producing a permanent specimen of cells, tissues and the like (herein, these are referred to as cells).
(従来の技術) 医学の発展に伴い広い範囲で免疫組織化学染色法が用い
られている。従来、パーオキシダーゼ(以下POXとい
う)で標識した抗体が多用されているが、試料中に存在
するPOXを染色に先立って失活させる操作が必要であ
り、この操作において発生する酸素が細胞や標本を崩壊
することがある。特に、骨髄や末梢血の塗沫標本、リン
パ節のスタンプ標本に応用するときには、細胞の損傷が
著しい。(Prior Art) With the development of medicine, immunohistochemical staining methods have been widely used. Conventionally, antibodies labeled with peroxidase (hereinafter referred to as POX) are often used, but it is necessary to inactivate the POX present in the sample prior to staining, and the oxygen generated in this operation is necessary for cells and specimens. May collapse. In particular, when applied to a smear sample of bone marrow or peripheral blood or a stamp sample of lymph node, cell damage is remarkable.
また、POX標識方法では、安定した色素を生成するベン
チジン系化合物を基質として用いるが、生成色素が褐色
のため、メラニン等の生体内色素との鑑別が困難であ
る。そして、安定した色素を生成する適当な基質は未だ
見いだされていない。In the POX labeling method, a benzidine compound that produces a stable dye is used as a substrate, but since the produced dye is brown, it is difficult to distinguish it from an in vivo dye such as melanin. And no suitable substrate has yet been found to produce stable dyes.
POX以外の標識酵素を用いる方法としては、アルカリフ
ォスファターゼ(以下APという)を用いる方法が知られ
ている。APを用いる方法の利点は、(1)通常のパラフ
ィン包埋切片において試料中に内在する酵素を失活させ
る必要がない。(2)使用基質に発癌性がない。(3)
ナフトール系の基質とジアゾニウム塩とのカップラーの
組み合わせによって色彩対比の優れた色素が得られる。
(4)アルカリ側の反応ため抗原抗体反応の解離の恐れ
が少ない、等が挙げられる。一方、欠点としては、生成
色素が、有機溶媒に可溶性で無水封入ができず、グリセ
リンゼリー等に封入するので、数カ月で褪色が生ずるこ
とである。As a method of using a labeling enzyme other than POX, a method of using alkaline phosphatase (hereinafter referred to as AP) is known. The advantage of the method using AP is that (1) it is not necessary to inactivate the enzyme existing in the sample in a normal paraffin-embedded section. (2) The substrate used is not carcinogenic. (3)
By combining a naphthol-based substrate and a coupler of a diazonium salt, a dye having excellent color contrast can be obtained.
(4) The reaction on the alkaline side is less likely to cause dissociation of the antigen-antibody reaction. On the other hand, a drawback is that the produced dye is soluble in an organic solvent and cannot be encapsulated in anhydrous form, and is encapsulated in glycerin jelly or the like, which causes fading in several months.
(発明が解決しようとする課題) 本発明は、従来のAPで細胞を標識して標本を作成する方
法の欠点を解消し、非水溶性の樹脂封入を可能にし、褪
色が少なく色素の局在性に優れた永久標本の作成方法を
提供しようとするものである。(Problems to be Solved by the Invention) The present invention solves the drawbacks of the conventional method of labeling cells with AP to prepare a specimen, enables water-insoluble resin encapsulation, has less fading, and localizes the dye. It is intended to provide a method of producing a permanent specimen having excellent properties.
(課題を解決するための手段) 本発明は、APで標識した細胞に、APの基質をpH8.2〜8.5
の範囲の緩衝液中で作用させて、生成した反応生成物と
塩基性フクシンのジアゾ化物とを反応させて生成する有
機溶媒不溶性の赤色色素を沈着させ、非水溶性の樹脂封
入剤で封入することを特徴とする細胞の永久標本の作成
方法である。(Means for Solving the Problem) In the present invention, cells labeled with AP are treated with AP substrate at a pH of 8.2 to 8.5.
The reaction product produced by reacting the reaction product with the diazotized product of basic fuchsin to deposit an organic solvent-insoluble red dye, which is then encapsulated with a water-insoluble resin encapsulant. It is a method for producing a permanent sample of cells, which is characterized in that
本発明の方法で染色できる細胞としては、APで標識する
ことのできるものであればいかなる細胞も対象とするこ
とができるが、具体的には、リンパ筋、脾臓、骨髄、肝
臓、腸管、神経、腎臓、内分泌線等の組織および血液、
腹水、脳脊髄液、肺胞洗浄液等の遊離細胞を挙げること
ができる。The cells that can be stained by the method of the present invention can be any cells as long as they can be labeled with AP, and specifically, lymph muscle, spleen, bone marrow, liver, intestinal tract, nerves. , Kidneys, tissues such as endocrine glands and blood,
Examples include free cells such as ascites fluid, cerebrospinal fluid, and alveolar lavage fluid.
また、本発明の方法に用いる試料の形態としては、パラ
フィン包埋切片、凍結切片、塗沫標本、細胞遠心標本等
を挙げることができる。In addition, examples of the form of the sample used in the method of the present invention include paraffin-embedded sections, frozen sections, smear samples, and cytocentrifuge samples.
APで細胞に標識する方法としては、その自体公知の手法
がいずれも適用することができる。例えば、細胞中の抗
原にAPを直接結合して標識する直接法と、細胞中の抗原
に第1次抗体を反応させ、ビオチン化第2次抗体をさら
に反応させ、該第2次抗体に対してAPを結合させて標識
する間接法とがある。As a method for labeling cells with AP, any method known per se can be applied. For example, a direct method in which AP is directly bound to an antigen in a cell to label the antigen, a primary antibody is reacted with an antigen in the cell, and a biotinylated secondary antibody is further reacted to the secondary antibody. There is an indirect method in which AP is bound and labeled.
APを抗体に結合する方法としては、例えば、グルタール
アルデヒドや過ヨウ酸酸化法等の化学結合による方法、
AP抗AP法など仲介を介して結合する方法等、公知の手法
をいずれも採用することができる。これらの酵素標識方
法は、例えば酵素抗体法(学際企画出版、昭和60年3月
25日発行)に記載されている。As a method for binding AP to an antibody, for example, a method by chemical bonding such as glutaraldehyde or periodate oxidation method,
Any known method such as a method of binding via an intermediary such as an AP anti-AP method can be adopted. These enzyme labeling methods include, for example, the enzyme antibody method (Interdisciplinary Planning Publishing, March 1985).
Issued on 25th).
本発明で使用することのできる第1次抗体としては、家
兎抗ヒト特異抗体(抗ヒトイムノグロブリン、抗ヒトリ
ゾチーム、抗ヒト癌胎児性タンパク、抗ヒトケラチン、
抗ヒト白血球共通抗原)、及び、マウス抗ヒト特異モノ
クロナール抗体等を挙げることができ、また、第2次抗
体としては、山羊抗家兎イムノグロブリン、家兎抗マウ
ス・イムノグロブリン等を挙げることができる。The primary antibodies that can be used in the present invention include rabbit anti-human specific antibodies (anti-human immunoglobulin, anti-human lysozyme, anti-human carcinoembryonic protein, anti-human keratin,
Anti-human leukocyte common antigen), mouse anti-human specific monoclonal antibody, etc., and secondary antibodies include goat anti-rabbit immunoglobulin, rabbit anti-mouse immunoglobulin, etc. You can
また、本発明で使用することのできるAPの基質として
は、ナフトールAS-MXリン酸、ナフトールAB-BIリン酸、
αナフチルリン酸、ナフトールAS-GR及びそれらの塩等
を挙げることができる。Further, as a substrate for AP that can be used in the present invention, naphthol AS-MX phosphate, naphthol AB-BI phosphate,
Examples include α-naphthylphosphoric acid, naphthol AS-GR and salts thereof.
さらに、酵素反応生成物と反応させるカップラーとして
用いられる塩基性フクシンは、例えば、下記式で表され
る化合物等を挙げることができる。これらの化合物は、
ジアゾ化して用いる。Furthermore, examples of the basic fuchsin used as a coupler for reacting with an enzymatic reaction product include compounds represented by the following formulas. These compounds are
Used after diazotization.
上記の発色反応に続いてヘマトキシリンを用いて青色に
核染色することも可能である。この方法は、細胞を赤色
に染色し、核を青色に染色するため、色彩のコトラスト
が鮮明となり、細胞の同定を容易にする。なお、その他
の染色法も、必要に応じて適宜採用することができる。 Following the above color development reaction, it is also possible to perform nuclear staining in blue with hematoxylin. According to this method, cells are stained red and nuclei are stained blue, so that the color contrast becomes clear and the cells can be easily identified. It should be noted that other dyeing methods can be appropriately adopted as necessary.
以上の酵素反応をpH8.2〜8.5の範囲の緩衝液中で行うこ
とにより、抗原抗体反応の解離が抑制され、形成された
色素の拡散を防止することができ、そして、赤色で、し
かも有機溶媒不溶性の反応産物を生成できるので、染色
後の細胞を非水溶性樹脂に封入することが可能となっ
た。By performing the above enzyme reaction in a buffer solution with a pH range of 8.2 to 8.5, the dissociation of the antigen-antibody reaction can be suppressed, the diffusion of the formed dye can be prevented, and the red color and the organic Since a solvent-insoluble reaction product can be produced, the stained cells can be encapsulated in a water-insoluble resin.
発色反応終了後の細胞は、イソプロピルアルコール等に
より処理し、パラフィン包埋組織については、さらに、
キシロール処理を行い、その他の試料については直接、
エイビー・ウィル・ベッカー社製のダイアテックス、メ
ルク社製エンテランニュー等の非水溶性の樹脂封入剤で
封入する。The cells after the color reaction are treated with isopropyl alcohol or the like, and the paraffin-embedded tissue is further treated with
Perform xylol treatment and directly for other samples,
Encapsulate with a water-insoluble resin encapsulant such as Avi Will Becker's Diatex or Merck's Enteran New.
(作用) 本発明は、APで標識した細胞のAPを、APの基質に作用さ
せ、生成する反応生成物と塩基性フクシンのジアゾ化物
とを反応させて、有機溶媒不溶性の赤色色素を生成さ
せ、これを細胞に沈着させて細胞を染色し、脱水した後
非水溶性樹脂封入剤で封入して永久標本を作成する方法
である。ここで生成する色素は、細胞に対して局在性に
優れており、細胞に沈着後の色素の拡散もなく、非水溶
性樹脂封入、即ち、無水封入を可能とし、長期間褪色の
ない永久標本の作成を可能とする。また、ヘマトキシリ
ンによる青色の対比核染色するときには、組織の赤色に
対して核の青色が鮮明なコントラストを形成し、細胞の
同定を容易にする。さらに、POX標識による二重染色を
行うことも可能となった。(Action) The present invention allows AP labeled cells to act on the AP substrate and react the resulting reaction product with the basic fuchsin diazotized product to produce an organic solvent insoluble red dye. This is a method of depositing this on cells to stain the cells, dehydrating them, and then encapsulating with a water-insoluble resin encapsulating agent to prepare a permanent specimen. The dye generated here has excellent localization to cells, does not diffuse the dye after being deposited on cells, and enables water-insoluble resin encapsulation, that is, anhydrous encapsulation, and is a permanent dye that does not fade for a long period of time. Allows creation of specimens. Further, when blue counternuclear staining with hematoxylin is performed, the blue color of the nucleus forms a clear contrast with the red color of the tissue, which facilitates the identification of cells. Furthermore, it became possible to perform double staining with POX labeling.
(実施例1) リンパ筋を20%ホルマリンで固定した後、パラフィンで
包埋した組織を用いて永久標本を作成した。(Example 1) After fixing lymph muscle with 20% formalin, a permanent specimen was prepared using a tissue embedded in paraffin.
まず、0.1%ネオプレンのトルエン溶液で前処理し
たスライドグラス上に、上記の包埋組織を4μmの厚さ
に薄切りした切片を伸展させ、キシロールに浸漬して脱
パラフィンした後、リン酸緩衝液で洗浄して試料を調整
した。First, on a slide glass pretreated with a 0.1% neoprene toluene solution, a slice of the above-embedded tissue was sliced to a thickness of 4 μm, extended, dipped in xylol and deparaffinized, and then with a phosphate buffer solution. The sample was prepared by washing.
次いで、5%正常山羊血清を塗沫して室温で15分間
反応させ、一旦、リン酸緩衝液で洗浄した後、第1次抗
体として家兎抗ヒトイムノグロブリンを塗沫して室温で
60分間反応させ、再び、リン酸緩衝液で洗浄した。そし
て、ビオチン化第2次抗体として、ベクター社製ビオチ
ン化山羊抗家兎イムノグロブリンを塗沫して室温で30分
間反応させ、リン酸緩衝液による洗浄後、さらに、アル
カリフォスファターゼで標識したアビジンとしてはバイ
オイエダ社製アルカリフォスファターゼ標識アビジンを
塗沫して室温で30分間反応させてから、リン酸緩衝液で
洗浄して、AP標識の細胞を得た。Then, smear 5% normal goat serum, react at room temperature for 15 minutes, wash once with phosphate buffer, and smear rabbit anti-human immunoglobulin as primary antibody at room temperature.
The mixture was reacted for 60 minutes and washed again with a phosphate buffer. Then, as a biotinylated secondary antibody, biotinylated goat anti-rabbit immunoglobulin manufactured by Vector Co., Ltd. was applied, reacted at room temperature for 30 minutes, washed with a phosphate buffer, and further, as avidin labeled with alkaline phosphatase. Was applied with Bio-Yeda alkaline phosphatase-labeled avidin, reacted at room temperature for 30 minutes, and then washed with a phosphate buffer to obtain AP-labeled cells.
一方、基質としてナフトールAS-BIリン酸10mgを0.2
mlのジメチルホルムアミドに溶解した。また、カップリ
ング液としてフクシンNBの4gを2N塩酸100mlに溶解し、
ろ過して0.1mlのろ液を採取し、4gの亜硝酸ナトリウム
を100mlの蒸留水に溶解し、フクシンNB液と亜硝酸ナト
リウムとを0.1mlづつ採取して混合し、黄褐色の透明液
を得た。この透明液を9.6mgのL-レバミゾールを含む0.2
Mトリス塩酸緩衝液(pH8.5)40mlに溶解し、これに0.2m
lの基質液を加えて撹拌し、次いでろ過した。On the other hand, as a substrate, naphthol AS-BI phosphate 10 mg 0.2
It was dissolved in ml of dimethylformamide. Further, 4 g of Fuchsin NB as a coupling solution was dissolved in 100 ml of 2N hydrochloric acid,
A 0.1 ml filtrate was collected by filtration, 4 g of sodium nitrite was dissolved in 100 ml of distilled water, and 0.1 ml of Fuchsin NB solution and sodium nitrite were collected and mixed to give a yellow-brown transparent liquid. Obtained. This clear liquid was added with 9.6 mg of L-levamisole 0.2
Dissolve in 40 ml of M Tris-HCl buffer (pH 8.5) and add 0.2m to it.
l of substrate solution was added and stirred, and then filtered.
得られたろ液に、上記で得たAP標識細胞を浸漬し
て室温で15分間反応させ、リン酸緩衝液で洗浄した後、
20%ホルマリン液で固定して室温で10分間保持し、次い
で、ヘマトキシリン液により室温で2分間処理して核を
青色に染色した。In the obtained filtrate, the AP-labeled cells obtained above were immersed and reacted at room temperature for 15 minutes, and after washing with a phosphate buffer,
The cells were fixed with 20% formalin solution and kept at room temperature for 10 minutes, and then treated with hematoxylin solution for 2 minutes at room temperature to stain nuclei blue.
その後、イソプロピルアルコールで処理してから、
キシロールで脱水し、ダイアテックスで樹脂封入して永
久標本を得た。Then, treat with isopropyl alcohol,
It was dehydrated with xylol and resin-sealed with Diatex to obtain a permanent specimen.
このようにして得た永久標本は、赤色に染色され、優れ
た局在性を示し、また、核が青く染色されるために、コ
ントラストが鮮明となり、細胞の同定が一層容易になっ
た。そして、無水封入で、かつ、キシロール不溶性のた
め、長期間褪色が全く見られなかった。The permanent specimen thus obtained was stained red and showed excellent localization, and because the nucleus was stained blue, the contrast became clear and the identification of cells became easier. Since it was encapsulated in anhydrous and insoluble in xylol, no fading was observed for a long time.
また、脾臓、骨髄、肝臓及び腸管の包埋組織の試料につ
いても、上記を同様にして永久標本を作成したところ、
上記のリンパ筋永久標本と同様の結果を得た。In addition, for samples of embedded tissues of spleen, bone marrow, liver and intestinal tract, permanent samples were prepared in the same manner as above,
Results similar to those of the above-mentioned permanent lymph muscle specimen were obtained.
(実施例2) 骨髄の20%ホルマリン固定後の包埋組織について、実施
例1の手順中の基質として、ナフトールAS-BIリン酸
ナトリウム10mgを直接9.6mgのL-レバミゾールを含む0.2
Mトリス塩酸緩衝液(pH8.5)40mlに溶解したものを用い
た点を除き、実施例1と同様に永久標本を作成した。(Example 2) Regarding embedded tissue after fixing 20% formalin of bone marrow, as a substrate in the procedure of Example 1, naphthol AS-BI sodium phosphate 10 mg was directly added to 9.6 mg of L-levamisole 0.2.
A permanent sample was prepared in the same manner as in Example 1 except that the solution was dissolved in 40 ml of M Tris-HCl buffer (pH 8.5).
得られた標本は、実施例1と同様に鮮やかな対比染色が
なされ、長期間褪色のない、組織の同定の容易な永久標
本を得ることができた。The obtained specimen was subjected to vivid counterstaining in the same manner as in Example 1, and a permanent specimen without fading for a long period of time with easy tissue identification could be obtained.
(実施例3) 末梢血液の塗沫標本を無水アセトンで固定して5分間保
持した後、乾燥し、リン酸緩衝液で洗浄することによ
り、試料を調整した。Example 3 A sample was prepared by fixing a smear of peripheral blood with anhydrous acetone, holding it for 5 minutes, drying, and washing with a phosphate buffer.
次いで、実施例1の〜の手順に従って処理をすすめ
てAP標識細胞を作成し、2重染色を施した後、イソプロ
ピルアルコールで処理し、直ちにダイアテックスで封入
した。Then, the treatment was promoted according to the procedure of to in Example 1 to prepare AP-labeled cells, which were double-stained, treated with isopropyl alcohol, and immediately mounted with Diatex.
得られた標本は、細胞の損傷もみられず、実施例1と同
様に鮮やかな対比染色がなされ、長期間褪色のない、細
胞同定の容易な永久標本を得ることができた。The obtained specimen did not show any cell damage, was subjected to bright counterstaining as in Example 1, and a permanent specimen without fading for a long period of time and with easy cell identification could be obtained.
また、骨髄の塗沫標本、リンパ筋のスタンプ標本、腹水
の細胞遠心標本、並びに、リンパ筋、脾臓、骨髄、肝臓
及び腸管の凍結切片についても、上記と同様の手順で永
久標本を作成したところ、末梢血液の永久標本と同様の
結果を得た。In addition, a permanent sample was prepared by the same procedure as above for the smear of bone marrow, the stamp of lymph muscle, the cytocentrifuge of ascites, and the frozen sections of lymph muscle, spleen, bone marrow, liver and intestine. Similar results were obtained with a permanent sample of peripheral blood.
(発明の効果) 本発明は、上記の構成を採用することにより、有機溶媒
不溶性の色素で染色することができるので、非水溶性の
樹脂封入を可能とし、長期間褪色しない優れた永久標本
を提供することができるようになった。また、上記色素
は細胞に対して局在性の優れた染色を可能とし、かつ、
この色素は明るい赤色であるため、組織の色と区別が明
瞭となり、青色に核染色するときにはコントラストが鮮
やかになり、細胞の同定が一層容易に行うことができる
ようになった。(Advantages of the Invention) The present invention, by adopting the above-mentioned constitution, can stain with a dye insoluble in an organic solvent, so that a water-insoluble resin can be encapsulated and an excellent permanent specimen that does not fade for a long time can be obtained. It is now possible to provide. Further, the above dye enables staining with excellent localization to cells, and
Since this dye has a bright red color, it is clearly distinguished from the color of the tissue, the contrast becomes vivid when the nucleus is stained blue, and the cells can be identified more easily.
Claims (3)
にアルカリフォスファターゼの基質をpH8.2〜8.5の範囲
の緩衝液中で作用させ、生成した反応生成物と塩基性フ
クシンのジアゾ化物とを反応させて生成する有機溶媒不
溶性の赤色色素を沈着させ、非水溶性の樹脂封入剤で封
入することを特徴とする細胞の永久標本の作成方法。1. Formed by reacting alkaline phosphatase-labeled cells with an alkaline phosphatase substrate in a buffer solution having a pH range of 8.2 to 8.5, and reacting the generated reaction product with a basic fuchsin diazotized product. A method for producing a permanent specimen of cells, which comprises depositing an organic solvent-insoluble red pigment and encapsulating the pigment with a water-insoluble resin encapsulating agent.
オチン化第2次抗体をさらに反応させ、該第2次抗体に
対してアルカリフォスファターゼを結合させて標識とし
たことを特徴とする特許請求の範囲第1項記載の細胞の
永久標本の作成方法。2. A method comprising reacting a primary antibody with a light source in a cell, further reacting with a biotinylated secondary antibody, and binding alkaline phosphatase to the secondary antibody for labeling. The method for producing a permanent specimen of cells according to claim 1.
トキシリンによる青色の核染色をすることを特徴とする
特許請求の範囲第1項又は第2項記載の細胞の永久標本
の作成方法。3. The method for producing a permanent sample of cells according to claim 1 or 2, wherein blue nuclear staining with hematoxylin is performed before encapsulating with a water-insoluble resin encapsulating agent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61226454A JPH0711520B2 (en) | 1986-09-25 | 1986-09-25 | How to make a permanent sample of cells |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61226454A JPH0711520B2 (en) | 1986-09-25 | 1986-09-25 | How to make a permanent sample of cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6381267A JPS6381267A (en) | 1988-04-12 |
| JPH0711520B2 true JPH0711520B2 (en) | 1995-02-08 |
Family
ID=16845352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61226454A Expired - Lifetime JPH0711520B2 (en) | 1986-09-25 | 1986-09-25 | How to make a permanent sample of cells |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0711520B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119935989B (en) * | 2024-12-19 | 2026-03-31 | 卡秋(江苏)生物科技有限公司 | An alkaline phosphatase staining solution suitable for fully automated immunohistochemical staining instruments |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6047960A (en) * | 1983-08-26 | 1985-03-15 | Wako Pure Chem Ind Ltd | Staining method and staining test solution of cell in cytology |
| IL75020A (en) * | 1984-05-10 | 1988-10-31 | Abbott Lab | Biotin-antibiotin immunoassay for the detection of ligands |
-
1986
- 1986-09-25 JP JP61226454A patent/JPH0711520B2/en not_active Expired - Lifetime
Non-Patent Citations (1)
| Title |
|---|
| TheJournalofHistochemistryandCytochemistry,Vol.32,No.2(1984)(米)P.219−229 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6381267A (en) | 1988-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11740233B2 (en) | Antibody-nanoparticle conjugates and methods for making and using such conjugates | |
| Mason et al. | Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents. | |
| US4496722A (en) | Reporter compounds | |
| US4659817A (en) | Reporter compounds containing boron | |
| EP4220164A2 (en) | Methods and systems for quantitative immunohistochemistry | |
| CN105566499B (en) | A kind of polymer enzyme antibody and preparation method thereof | |
| Godman et al. | The composition of the LE and hematoxylin bodies of systemic lupus erythematosus | |
| JPH06508818A (en) | Preferential labeling of phycobiliproteins using a second dye to enable multiplexed color assays | |
| JP2005017133A (en) | Antigen detection method by immunohistochemical staining method | |
| JP2018520647A (en) | Compositions and methods for simultaneous inactivation of alkaline phosphatase and peroxidase enzymes during an automated multiple tissue staining assay | |
| CN113008649A (en) | Immunohistochemistry combined elastic fiber multiple dyeing kit, dyeing method and application | |
| CN108717120A (en) | A kind of cervical carcinoma screening detection kit | |
| CN110320087B (en) | Pigment-containing tissue immunohistochemical staining kit and staining method | |
| US7972789B2 (en) | Dye compounds | |
| CN108760444A (en) | Staining kit and colouring method for tissue fibers | |
| JPH0792460B2 (en) | Kit for detecting microorganisms associated with periodontal disease using surfactant mixture as extraction composition and method for detecting the same | |
| JPH0711520B2 (en) | How to make a permanent sample of cells | |
| CN103063849A (en) | A method for simultaneous detection of cancer-associated fibroblasts and expressed proteins thereof | |
| Sippel | The histochemistry of thiols and disulphides. I. The use of N-(4-aminophenyl) maleimide for demonstrating thiol groups | |
| Krenacs et al. | Multiple antigen immunostaining procedures | |
| Sippel | The histochemistry of thiols and disulphides. II. Methodology of differential staining | |
| JPH03251764A (en) | Buffering cleaning composition, test kit and method of its use | |
| CN117451468A (en) | Reagent combination for immunohistochemistry and Masson counterstaining, kit and use method | |
| EP0110879A1 (en) | Reporter compounds | |
| CN115975009A (en) | A kind of enhanced fluorescent antibody, its preparation method and application |